Dynasil Delivers Pilot Production Order for Proprietary Radiation Detection Technology to Thermo Fisher Scientific

  Dynasil Delivers Pilot Production Order for Proprietary Radiation Detection
  Technology to Thermo Fisher Scientific

      Dynasil’s Gamma-Neutron Scintillator Integrated into Thermo Fisher
           Scientific’s Market-Leading Personal Radiation Detectors

Business Wire

WATERTOWN, Mass. -- January 22, 2013

Dynasil Corporation of America (NASDAQ: DYSL) today announced that Thermo
Fisher Scientific Inc. (NYSE: TMO) is integrating the Company’s proprietary
gamma and neutron scintillator detection technology, known as CLYC, into the
Thermo Fisher Scientific RadEye® GN+ Personal Radiation Detector. The device
is being deployed to homeland security, defense and law enforcement agencies
worldwide.

The CLYC dual mode scintillator has been successfully commercialized through
Dynasil’s RMD and Hilger Crystals business units. The technology is capable of
detecting nuclear and radioactive materials in all environments and can be
used for both nuclear weapons detection and civilian radiation leak detection.
Developed by the Company’s RMD, Inc. business unit with funding from multiple
U.S. Government agencies, CLYC is the first dual mode (gamma and neutron)
scintillation detector commercialized for homeland security and defense
applications.

“Our CLYC technology simultaneously detects potentially harmful gamma-ray
sources and neutron-emitting elements while eliminating the need to use scarce
Helium-3 gas as their detection medium,” stated Dynasil Chairman, Interim
President and Chief Executive Officer Peter Sulick. “The ability to measure
two radiation sources with a single detector not only provides significant
cost benefits; it also saves valuable time by enabling first responders to
rapidly and more accurately detect a broader range of potential threats.”

About Dynasil

Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures
detection and analysis technology, precision instruments and optical
components for the homeland security, medical and industrial markets.
Combining world-class technology with expertise in research and materials
science, Dynasil is commercializing products including dual-mode radiation
detection solutions for Homeland Security and commercial applications, probes
for medical imaging and sensors for non-destructive testing. Dynasil has an
impressive and growing portfolio of issued and pending U.S. patents. The
Company is based in Watertown, Massachusetts, with additional operations in
Mass., Minn., NY, NJ and the United Kingdom. More information about the
Company is available at www.dynasil.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our
mission is to enable our customers to make the world healthier, cleaner and
safer. With revenues of $12 billion, we have approximately 39,000 employees
and serve customers within pharmaceutical and biotech companies, hospitals and
clinical diagnostic labs, universities, research institutions and government
agencies, as well as in environmental and process control industries. We
create value for our key stakeholders through three premier brands, Thermo
Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique
combination of innovative technologies, convenient purchasing options and a
single solution for laboratory operations management. Our products and
services help our customers solve complex analytical challenges, improve
patient diagnostics and increase laboratory productivity. Visit
www.thermofisher.com.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements regarding future events and our future results are based on current
expectations, estimates, forecasts, and projections and the beliefs and
assumptions of our management. These forward-looking statements may be
identified by the use of words such as “may,” “could,” “expect,” “estimate,”
“anticipate,” “continue” or similar terms, though not all forward-looking
statements contain such words. The actual results of the future events
described in such forward-looking statements could differ materially from
those stated in such forward-looking statements due to a number of important
factors. These factors that could cause actual results to differ from those
anticipated or predicted include, without limitation, our ability to develop
and commercialize our products, the size and growth of the potential markets
for our products and our ability to serve those markets, the rate and degree
of market acceptance of any of our products, general economic conditions,
costs and availability of raw materials and management information systems,
our ability to obtain and maintain intellectual property protection for our
products, competition, the loss of key management personnel, litigation, the
effect of governmental regulatory developments, the availability of financing
sources, our ability to identify and execute on acquisition opportunities and
integrate such acquisitions into our business, and seasonality, as well as the
uncertainties set forth in the Company’s Annual Report on Form 10-K and from
time to time in the Company's other filings with the Securities and Exchange
Commission. The Company disclaims any intention or obligation to update any
forward-looking statements, whether as a result of new information, future
events or otherwise.

Contact:

Dynasil Corporation of America
Patty Kehe
Corporate Secretary
617-668-6855
pkehe@dynasil.com
or
Sharon Merrill
David Calusdian
Executive Vice President and Partner
617-542-5300
DYSL@InvestorRelations.com
 
Press spacebar to pause and continue. Press esc to stop.